Latest MinervaX News & Updates

See the latest news and media coverage for MinervaX. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
MinervaX

Clinical-stage vaccine biotechnology company

minervax.com
Headquarters
Copenhagen, Denmark
Company type
Private company
Number of employees
10–83
Industry
Pharmaceuticals

Last updated

Latest news about MinervaX

In short: MinervaX appointed two executives as its maternal GBS vaccine advanced toward pivotal trials

Company announcements

MinervaX

MinervaX raises 72M EUR to advance GBS vaccine

It includes 22M EUR equity co-led by Trill Impact Ventures and Pureos Bioventures and a 50M EUR EIB loan facility, supporting Phase 3 preparation.

Unlock all announcements with a

Media coverage

Unquote

Sanofi et al. back €47m series-B for MinervaX

Existing investors Novo Holdings, Repair Impact Fund, Sunstone Life Science Ventures and LF Investment also joined the round. The proceeds will be used to advance...

Unlock all articles with a

Never miss news about MinervaX

Track MinervaX and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.